CLINICAL TRIALS PROFILE FOR PRASTERONE
✉ Email this page to a colleague
All Clinical Trials for Prasterone
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00006219 ↗ | Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma | Completed | National Cancer Institute (NCI) | Phase 2 | 2000-08-01 | RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Dehydroepiandrosterone and clarithromycin may be effective in preventing multiple myeloma. PURPOSE: Randomized phase II trial to compare the effectiveness of dehydroepiandrosterone with that of clarithromycin in treating patients who may be at a high risk of developing multiple myeloma. |
NCT00006219 ↗ | Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma | Completed | Mayo Clinic | Phase 2 | 2000-08-01 | RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Dehydroepiandrosterone and clarithromycin may be effective in preventing multiple myeloma. PURPOSE: Randomized phase II trial to compare the effectiveness of dehydroepiandrosterone with that of clarithromycin in treating patients who may be at a high risk of developing multiple myeloma. |
NCT00082511 ↗ | GL701 (Prestaraâ„¢) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids | Completed | Genelabs Technologies | Phase 3 | 2003-07-01 | Open label safety and efficacy follow-up. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Prasterone
Condition Name
Clinical Trial Locations for Prasterone
Trials by Country
Clinical Trial Progress for Prasterone
Clinical Trial Phase
Clinical Trial Sponsors for Prasterone
Sponsor Name